Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Oncolytics Biotech Inc (ONC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.47 -0.02    -1.34%
26/04 - Closed. Currency in CAD ( Disclaimer )
  • Volume: 14,646
  • Bid/Ask: 1.47 / 1.48
  • Day's Range: 1.45 - 1.49
Type:  Equity
Market:  Canada
Oncolytics Biotech 1.47 -0.02 -1.34%

ONC Financial Summary

 
A brief financial summary of Oncolytics Biotech Inc as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Oncolytics Biotech Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was CAD 27.75 million compared to CAD 24.84 million a year ago. Basic loss per share from continuing operations was CAD 0.41 compared to CAD 0.43 a year ago. Diluted loss per share from continuing operations was CAD 0.41 compared to CAD 0.43 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

ONC Income Statement

Gross margin TTM -
Operating margin TTM 0%
Net Profit margin TTM 0%
Return on Investment TTM -104.71%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue
Gross Profit
Operating Income -8.85 -11.05 -7.16 -6.73
Net Income -3.95 -9.92 -7.44 -6.44

ONC Balance Sheet

Quick Ratio MRQ 8.24
Current Ratio MRQ 9.01
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 1.53%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 38.82 46.09 31.97 35.33
Total Liabilities 11.26 17.07 9.73 9.58
Total Equity 27.56 29.02 22.24 25.75

ONC Cash Flow Statement

Cash Flow/Share TTM -0.38
Revenue/Share TTM -
Operating Cash Flow  -144.34%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -6.12 -6.03 -8.46 -7.83
Cash From Investing Activities -0.003 6.77 6.79 6.67
Cash From Financing Activities 1.74 21.29 3.69 5.27
Net Change in Cash -5.07 22.46 1.65 4.21
* In Millions of CAD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ONC Comments

Write your thoughts about Oncolytics Biotech Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Dina Gene
Dina Gene May 26, 2023 8:18
Saved. See Saved Items.
This comment has already been saved in your Saved Items
go ONC go!!! BRACELET-1 PH2 showing great results!
Garbage Bear
Garbage Bear Nov 23, 2020 14:31
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I wonder how much of this increase is due to their positive clinical results compared to stock market vaccine news.?
Michael Verkerke
Michael Verkerke Mar 24, 2020 14:57
Saved. See Saved Items.
This comment has already been saved in your Saved Items
There's more good news coming down the pipe before months end.
Bachir Nahed
Bachir Nahed Feb 20, 2020 10:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Fuck that shit the worse stock ever
Michael Verkerke
Michael Verkerke Feb 20, 2020 10:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Told ya it'd spike.
Michael Verkerke
Michael Verkerke Jan 20, 2020 15:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
She's gonna spike up any day here soon.
Dbankerphfive Dbankerphfive
Dbankerphfive Dbankerphfive Dec 30, 2019 16:01
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I sold 62 shares got my capital back. Let’s hope this will continue.
albert jornacion
albert jornacion Dec 30, 2019 13:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
should hv bought more than 100 shares
Shane beggs
Shane beggs Dec 27, 2019 12:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
maybe more buyers than sellers
Dbankerphfive Dbankerphfive
Dbankerphfive Dbankerphfive Dec 27, 2019 12:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why are they buying?
Joe Juresic
Joe Juresic Dec 27, 2019 12:30
Saved. See Saved Items.
This comment has already been saved in your Saved Items
biopharm, medicals seem to be the safe bet as they are a necessity for future... this one deals with cancers etc
Dbankerphfive Dbankerphfive
Dbankerphfive Dbankerphfive Dec 26, 2019 11:47
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anyone can tell why it’s gaining?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email